Skip to main content

Free Content Pharmacological Interventions to Decompression Sickness in Rats: Comparison of Five Agents

Download Article:
 Download
(HTML 79.4912109375 kb)
 
or
 Download
(PDF 504.822265625 kb)
 
Montcalm-Smith EA, Fahlman A, Kayar SR. Pharmacological interventions to decompression sickness in rats: comparison of five agents. Aviat Space Environ Med 2008; 79:7–13.



Introduction: This research investigated whether decompression sickness (DCS) risk or severity could be reduced using drug interventions that are easier to implement and equal to or more efficacious than recompression therapy. Methods: Using a rat model of DCS, anti-inflammatory or anticoagulant drugs, including lidocaine, aspirin (ASA), methylprednisolone (MP), alpha-phenyl-N-butylnitrone (PBN), and transsodium crocetinate (TSC) were tested to determine their effect on incidence of DCS, death, and time of symptom onset. Each treatment group consisted of ∼40 animals that received the drug and ∼40 controls. Animals were exposed to one of five compression and decompression profiles with pressure ranging from 6.3 ATA (175 fsw) to 8.0 ATA (231 fsw); bottom time was either 60 or 90 min; and decompression rate was either 1.8 or 15 ATA ยท min−1. Following decompression, the rats were observed for 30 min while walking on a wheel. DCS was defined as an ambulatory deficit or abnormal breathing. Results: None of the drugs reached statistical significance for all DCS manifestations. Lidocaine post-dive and MP were the only treatments with marginally (P < 0.15) significant differences in DCS outcomes compared to controls. Lidocaine post-dive significantly decreased the incidence of neurological DCS from 73–51%. MP significantly extended the time of onset of death from DCS from 5.4 min to 7.1 min. Discussion: Of the treatments investigated, lidocaine given post-dive has the best chance of success in adjuvant therapy of DCS. Future studies might investigate adjuvant drugs given in combination or during recompression.

38 References.

No Supplementary Data.
No Data/Media
No Metrics

Keywords: DCS; adjunctive therapy; alpha-phenyl-N-butylnitorne; aspirin; lidocaine; methylprednisolone; transsodium crocetinate

Document Type: Research Article

Affiliations: From the Naval Medical Research Center, Silver Spring, MD (E. A. Montcalm-Smith, S. R. Kayar), and the UBC Marine Mammal Research Unit, The University of British Columbia, Vancouver, BC, Canada (A. Fahlman).

Publication date: 2008-01-01

More about this publication?
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more